Cambrex Karlskoga
Sweden
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (9)
✓ EMA GMP (5)
○ MHRA GMP
✓ HC GMP (5)
Quick Facts: Cambrex Karlskoga
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Sweden
- Website
- https://www.cambrex.com
- Modalities
- Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Cambrex Karlskoga
Cambrex Karlskoga is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.cambrex.com
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Cambrex Karlskoga FDA Inspection History
2024-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-05-24 |
Cambrex Karlskoga AB
Karlskoga
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Cambrex Karlskoga EMA GMP Compliance 5 certificates
2026-05
2026-05
2026-05
2026-05
2026-05
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| SE-H-API-26-004189 | Cambrex Karlskoga AB | Sweden | 2026-05-29 | COMPLIANT |
| SE-H-API-26-075517 | Cambrex Karlskoga AB | Sweden | 2026-05-29 | COMPLIANT |
| SE-H-API-26-075539 | Cambrex Karlskoga AB | Sweden | 2026-05-29 | COMPLIANT |
| SE-H-API-26-075601 | Cambrex Karlskoga AB | Sweden | 2026-05-29 | COMPLIANT |
| SE-V-API-26-004189 | Cambrex Karlskoga AB | Sweden | 2026-05-29 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 31, 2026
Hiring Activity 2 open roles Beta
From public job postings on the parent company's careers board, as of Oct 30, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
2
open roles
0
in manufacturing, quality, PD/MSAT, engineering or regulatory (0%)
Trend from Nov 29, 2026
Tracking started Oct 30, 2026. 30-day change shows after 30 days, 90-day after Jan 28, 2027.
By function
By site
Karlskoga, Värmlands län, Sweden
· 2 other 2
· 2 other 2
Latest postings
Ekonomiassistent
Other (finance, HR, IT, other) · Karlskoga, Värmlands län, Sweden · posted Oct 28, 2026
Fabrikschef F16
Other (finance, HR, IT, other) · Karlskoga, Värmlands län, Sweden · posted Oct 16, 2026
Coverage: read from the parent company's careers board and kept only postings at this business's sites (group board filtered to the profile site (Karlskoga, Sweden); every counted posting has a JSON-LD location). Roles outside those sites are left out, and some of this unit's roles may be missed.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
careers.cambrex.com
· Checked Oct 30, 2026 · Tracking since Oct 30, 2026
Company Signals 9 articles
Company announcements, not verified evidence. They do not change any score.
Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience - PR Newswire
PE firm to buy Cambrex for $2.4B amid flurry of CDMO acquisitions - BioPharma Dive
UPDATE: Noramco divestment continues as it re-establishes CDMO Halo Pharma - Fierce Pharma
Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility - Eastern Progress
Cambrex to drop $120M to expand US operations amid industry's breakneck onshoring drive - Fierce Pharma
Cambrex makes three senior appointments - Cleanroom Technology
cbm-ex991_8.htm - SEC.gov
Cambrex Advances U.S. and European Expansions - Contract Pharma
Cambrex Commits $120 Million to Grow US API Manufacturing - Pharmaceutical Commerce
Frequently Asked Questions About Cambrex Karlskoga
How many FDA inspections does Cambrex Karlskoga have on record?
CDMO Signal tracks 1 FDA inspection for Cambrex Karlskoga, sourced from the FDA inspection database. See the full inspection history above.
Has Cambrex Karlskoga received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Cambrex Karlskoga.
Does Cambrex Karlskoga hold EMA or MHRA GMP certificates?
CDMO Signal tracks 5 EMA GMP certificates for Cambrex Karlskoga.
Does Cambrex Karlskoga have a CDMO Signal Score?
Not yet. Cambrex Karlskoga is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Cambrex Karlskoga for a manufacturing program?
Use the free AI matchmaker to compare Cambrex Karlskoga against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Olon
Rodano (Milano), Italy
Small Molecule API, Biologics, ADC / Bioconjugation
Sterling Pharma Solutions
Cramlington, United Kingdom
Small Molecule API, High-Potency APIs, Peptides, ADC / Bioconjugation, Controlled Substances, Clinical Trial Manufacturing
Veranova
United States
Small Molecule API, ADC / Bioconjugation
Sai Life Sciences
India
Small Molecule API
EUROAPI
France
Small Molecule API, Oligonucleotide, Peptides, Lipids, Microbial Fermentation, Particle Engineering
Compare Cambrex Karlskoga with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.